Literature DB >> 23246474

IL-33 promotes eosinophilia in vivo and antagonizes IL-5-dependent eosinophil hematopoiesis ex vivo.

Kimberly D Dyer1, Caroline M Percopo, Helene F Rosenberg.   

Abstract

IL-33 is an IL-1 family cytokine that elicits IL-5-dependent eosinophilia in vivo. We show here that IL-33 promotes minimal eosinophil hematopoiesis via direct interactions with mouse bone marrow progenitors ex vivo and that it antagonizes eosinophil hematopoiesis promoted by IL-5 on SCF and Flt3L primed bone marrow progenitor cells in culture. SCF and Flt3L primed progenitors respond to IL-33 by acquiring an adherent, macrophage-like phenotype, and by releasing macrophage-associated cytokines into the culture medium. IL-33-mediated antagonism of IL-5 was reproduced in part by the addition of GM-CSF and was inhibited by the actions of neutralizing anti-GM-CSF antibody. These findings suggest that the direct actions of IL-33 on bone marrow progenitors primed with SCF and Flt3L are antagonistic to the actions of IL-5 and are mediated in part by GM-CSF. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246474      PMCID: PMC3602230          DOI: 10.1016/j.imlet.2012.12.002

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  43 in total

Review 1.  c-Kit--a hematopoietic cell essential receptor tyrosine kinase.

Authors:  Charlotte E Edling; Bengt Hallberg
Journal:  Int J Biochem Cell Biol       Date:  2007-01-20       Impact factor: 5.085

2.  Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow.

Authors:  Kimberly D Dyer; Jennifer M Moser; Meggan Czapiga; Steven J Siegel; Caroline M Percopo; Helene F Rosenberg
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

3.  Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils.

Authors:  Maho Suzukawa; Rikiya Koketsu; Motoyasu Iikura; Susumu Nakae; Kenji Matsumoto; Hiroyuki Nagase; Hirohisa Saito; Kouji Matsushima; Ken Ohta; Kazuhiko Yamamoto; Masao Yamaguchi
Journal:  Lab Invest       Date:  2008-09-01       Impact factor: 5.662

4.  A novel IL-1 family cytokine, IL-33, potently activates human eosinophils.

Authors:  W Brett Cherry; Juhan Yoon; Kathleen R Bartemes; Koji Iijima; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2008-06       Impact factor: 10.793

5.  An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor.

Authors:  Maho Suzukawa; Motoyasu Iikura; Rikiya Koketsu; Hiroyuki Nagase; Chise Tamura; Akiko Komiya; Susumu Nakae; Kouji Matsushima; Ken Ohta; Kazuhiko Yamamoto; Masao Yamaguchi
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 6.  IL-5 and eosinophilia.

Authors:  Kiyoshi Takatsu; Hiroshi Nakajima
Journal:  Curr Opin Immunol       Date:  2008-05-27       Impact factor: 7.486

7.  Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo.

Authors:  Kimberly D Dyer; Meggan Czapiga; Barbara Foster; Paul S Foster; Elizabeth M Kang; Courtney M Lappas; Jennifer M Moser; Nora Naumann; Caroline M Percopo; Steven J Siegel; Jonathan M Swartz; Suksee Ting-De Ravin; Helene F Rosenberg
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

8.  IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.

Authors:  Mariola Kurowska-Stolarska; Pete Kewin; Grace Murphy; Remo C Russo; Bartosz Stolarski; Cristiana Couto Garcia; Mousa Komai-Koma; Nick Pitman; Yubin Li; Wanda Niedbala; Andrew N J McKenzie; Mauro M Teixeira; Foo Y Liew; Damo Xu
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

9.  The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

Authors:  Christine Moussion; Nathalie Ortega; Jean-Philippe Girard
Journal:  PLoS One       Date:  2008-10-06       Impact factor: 3.240

Review 10.  Eosinophils: changing perspectives in health and disease.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Paul S Foster
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106

View more
  18 in total

Review 1.  Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis.

Authors:  Ben A Croker; John Silke; Motti Gerlic
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

2.  Bone marrow type 2 innate lymphoid cells: a local source of interleukin-5 in interleukin-33-driven eosinophilia.

Authors:  Kristina Johansson; Carina Malmhäll; Patricia Ramos-Ramírez; Madeleine Rådinger
Journal:  Immunology       Date:  2017-10-19       Impact factor: 7.397

3.  IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils.

Authors:  Valeria Lucarini; Giovanna Ziccheddu; Iole Macchia; Valentina La Sorsa; Francesca Peschiaroli; Carla Buccione; Antonella Sistigu; Massimo Sanchez; Sara Andreone; Maria Teresa D'Urso; Massimo Spada; Daniele Macchia; Claudia Afferni; Fabrizio Mattei; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

4.  Eosinophil-associated ribonuclease 11 is a macrophage chemoattractant.

Authors:  Kelsey J Yamada; Tolga Barker; Kimberly D Dyer; Tyler A Rice; Caroline M Percopo; Katia E Garcia-Crespo; Soochin Cho; James J Lee; Kirk M Druey; Helene F Rosenberg
Journal:  J Biol Chem       Date:  2015-02-20       Impact factor: 5.157

5.  Functional interleukin-33 receptors are expressed in early progenitor stages of allergy-related granulocytes.

Authors:  Hirofumi Tsuzuki; Yojiro Arinobu; Kohta Miyawaki; Ayako Takaki; Shun-Ichiro Ota; Yuri Ota; Hiroki Mitoma; Mitsuteru Akahoshi; Yasuo Mori; Hiromi Iwasaki; Hiroaki Niiro; Hiroshi Tsukamoto; Koichi Akashi
Journal:  Immunology       Date:  2016-09-30       Impact factor: 7.397

Review 6.  The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation.

Authors:  Heather O'Leary; Xuan Ou; Hal E Broxmeyer
Journal:  Curr Opin Hematol       Date:  2013-07       Impact factor: 3.284

7.  Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.

Authors:  Tao Liu; Yoshihide Kanaoka; Nora A Barrett; Chunli Feng; Denise Garofalo; Juying Lai; Kathleen Buchheit; Neil Bhattacharya; Tanya M Laidlaw; Howard R Katz; Joshua A Boyce
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422

8.  Evaluation of biomaterial scaffold delivery of IL-33 as a localized immunomodulatory agent to support cell transplantation in adipose tissue.

Authors:  Jeffrey M H Liu; Xiaomin Zhang; Shelby Joe; Xunrong Luo; Lonnie D Shea
Journal:  J Immunol Regen Med       Date:  2018-02-22

Review 9.  Necroinflammation emerges as a key regulator of hematopoiesis in health and disease.

Authors:  Philipp J Jost; Ulrike Höckendorf
Journal:  Cell Death Differ       Date:  2018-09-21       Impact factor: 15.828

10.  IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis.

Authors:  Laura K Johnston; Chia-Lin Hsu; Rebecca A Krier-Burris; Krishan D Chhiba; Karen B Chien; Andrew McKenzie; Sergejs Berdnikovs; Paul J Bryce
Journal:  J Immunol       Date:  2016-09-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.